FDA Inspection 814083 — UCLA Medical IRB 1 (OHRPP)

UCLA Medical IRB 1 (OHRPP) — FEI 2080391

The FDA completed an inspection of UCLA Medical IRB 1 (OHRPP) on Dec 10, 2012 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 10, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

IRB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.